These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8214188)

  • 21. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
    Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Result of chronic levodopa therapy and its modification by bromocriptine in Parkinson's disease.
    Hoehn MM
    Acta Neurol Scand; 1985 Feb; 71(2):97-106. PubMed ID: 3984685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Letter: Psychosis in patient on bromocriptine and levodopa with carbidopa.
    Lipper S
    Lancet; 1976 Sep; 2(7985):571-2. PubMed ID: 60643
    [No Abstract]   [Full Text] [Related]  

  • 24. [CB 154 in the treatment of Parkinson's disease. Results in combination with L-dopa and decarboxylase inhibitor].
    Meco G; Casacchia M; Zamponi A; Agnoli A
    Acta Neurol (Napoli); 1976; 31(4):479-48. PubMed ID: 1037427
    [No Abstract]   [Full Text] [Related]  

  • 25. Drugs for parkinsonism.
    Med Lett Drugs Ther; 1986 Jun; 28(716):62-4. PubMed ID: 3713639
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of parkinsonism.
    Calne DB; Teychenne PF; Pfeiffer RF
    Adv Exp Med Biol; 1977; 90():49-61. PubMed ID: 930750
    [No Abstract]   [Full Text] [Related]  

  • 27. Hallucinosis in idiopathic Parkinson's disease.
    Graham JM; Grünewald RA; Sagar HJ
    J Neurol Neurosurg Psychiatry; 1997 Oct; 63(4):434-40. PubMed ID: 9343119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of early Parkinson's disease: are complicated strategies justified?
    Ahlskog JE
    Mayo Clin Proc; 1996 Jul; 71(7):659-70. PubMed ID: 8656708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hallucinations in Parkinson's disease].
    Moser A; Hagenah J; Kömpf D
    Nervenarzt; 2003 Apr; 74(4):376-85, quiz 385-6. PubMed ID: 12707709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levodopa compared with bromocriptine in the treatment of Parkinson's disease.
    Godwin-Austen RB
    Adv Biochem Psychopharmacol; 1980; 23():261-5. PubMed ID: 7395616
    [No Abstract]   [Full Text] [Related]  

  • 31. Hyperthermia after discontinuance of levodopa and bromocriptine therapy: impaired dopamine receptors a possible cause.
    Figà-Talamanca L; Gualandi C; Di Meo L; Di Battista G; Neri G; Lo Russo F
    Neurology; 1985 Feb; 35(2):258-61. PubMed ID: 3969217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clozapine withdrawal symptoms in a Parkinson's disease patient.
    Zesiewicz TA; Borra S; Hauser RA
    Mov Disord; 2002 Nov; 17(6):1365-7. PubMed ID: 12465085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hallucinations caused by paroxetine in combined usage of levodopa-carbidopa].
    Steur EN
    Ned Tijdschr Geneeskd; 2002 Jun; 146(22):1056-7; author reply 1057. PubMed ID: 12073510
    [No Abstract]   [Full Text] [Related]  

  • 34. Increased dosage of carbidopa in patients with Parkinson's disease receiving low doses of levodopa. A pilot study.
    Hoehn MM
    Arch Neurol; 1980 Mar; 37(3):146-9. PubMed ID: 7356419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parkinson's disease: recent advances in therapy.
    Jankovic J
    South Med J; 1988 Aug; 81(8):1021-7. PubMed ID: 3043683
    [No Abstract]   [Full Text] [Related]  

  • 36. Update on drug treatment of Parkinsonism.
    Winkelman AC
    Am Fam Physician; 1977 Jul; 16(1):118-20. PubMed ID: 18001
    [No Abstract]   [Full Text] [Related]  

  • 37. Bilateral vocal cord paralysis in Parkinson's disease.
    Plasse HM; Lieberman AN
    Arch Otolaryngol; 1981 Apr; 107(4):252-3. PubMed ID: 7213187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists.
    Klawans HL; Paleologos N
    Clin Neuropharmacol; 1986; 9(3):298-302. PubMed ID: 3719575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of Parkinson's syndrome with a combination of levodopa and carbidopa].
    Lombardo L; De la Garza R
    Arch Invest Med (Mex); 1977; 8(2):123-8. PubMed ID: 907417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. International symposium on early dopamine agonist therapy of Parkinson's disease.
    Arch Neurol; 1988 Feb; 45(2):204-8. PubMed ID: 3341935
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.